↓ Skip to main content

T cell activation and anti-tumor efficacy of anti-LAG-3 antibodies is independent of LAG-3 – MHCII blocking capacity

Overview of attention for article published in Journal for Immunotherapy of Cancer, November 2015
Altmetric Badge

About this Attention Score

  • Above-average Attention Score compared to outputs of the same age (58th percentile)
  • Above-average Attention Score compared to outputs of the same age and source (53rd percentile)

Mentioned by

patent
2 patents

Citations

dimensions_citation
2 Dimensions

Readers on

mendeley
21 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
T cell activation and anti-tumor efficacy of anti-LAG-3 antibodies is independent of LAG-3 – MHCII blocking capacity
Published in
Journal for Immunotherapy of Cancer, November 2015
DOI 10.1186/2051-1426-3-s2-p183
Authors

Saso Cemerski, Shuxia Zhao, Melissa Chenard, Jason Laskey, Long Cui, Rinkan Shukla, Brian Haines, Edward Hsieh, Maribel Beaumont, Jeanine Mattson, Wendy Blumenschein, Heather Hirsch, Laurence Fayadat-Dilman, Linda Liang, Rene De Waal Malefyt

Mendeley readers

The data shown below were compiled from readership statistics for 21 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United Kingdom 1 5%
Australia 1 5%
Unknown 19 90%

Demographic breakdown

Readers by professional status Count As %
Researcher 6 29%
Student > Ph. D. Student 4 19%
Student > Bachelor 3 14%
Other 3 14%
Student > Master 2 10%
Other 0 0%
Unknown 3 14%
Readers by discipline Count As %
Biochemistry, Genetics and Molecular Biology 5 24%
Agricultural and Biological Sciences 5 24%
Immunology and Microbiology 4 19%
Medicine and Dentistry 2 10%
Engineering 1 5%
Other 0 0%
Unknown 4 19%

Attention Score in Context

This research output has an Altmetric Attention Score of 3. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 19 December 2019.
All research outputs
#5,615,371
of 17,381,824 outputs
Outputs from Journal for Immunotherapy of Cancer
#973
of 1,747 outputs
Outputs of similar age
#114,905
of 283,888 outputs
Outputs of similar age from Journal for Immunotherapy of Cancer
#64
of 140 outputs
Altmetric has tracked 17,381,824 research outputs across all sources so far. This one is in the 47th percentile – i.e., 47% of other outputs scored the same or lower than it.
So far Altmetric has tracked 1,747 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 13.7. This one is in the 38th percentile – i.e., 38% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 283,888 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 58% of its contemporaries.
We're also able to compare this research output to 140 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 53% of its contemporaries.